CHARACTERISTICS OF INVITRO ANTI-PROLIFERATION ACTIVITY OF HUMAN INTERFERON-BETA

被引：26

作者：

KATAOKA, T ^{[1
]}

OHHASHI, F ^{[1
]}

SAKURAI, Y ^{[1
]}

IDA, N ^{[1
]}

机构：

[1] TORAY IND INC,BAS RES LABS,KAMAKURA,KANAGAWA 248,JAPAN

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1982年 / 9卷 / 02期

关键词：

D O I：

10.1007/BF00265382

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：75 / 80

页数：6

共 8 条

[1]

[Anonymous], 1979, INTERFERON SYSTEM

[2] THE CLINICAL-VALUE OF INTERFERONS AS ANTI-TUMOR AGENTS [J].

BILLIAU, A .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1981, 17 (09) :949-967

[3]

BRADLEY EC, 1981, CANCER RES, V41, P244

[4] IS INTERFERON TISSUE SPECIFIC - EFFECT OF HUMAN LEUKOCYTE AND FIBROBLAST INTERFERONS ON GROWTH OF LYMPHOBLASTOID AND OSTEOSARCOMA CELL LINES [J].

EINHORN, S ;

STRANDER, H .

JOURNAL OF GENERAL VIROLOGY, 1977, 35 (JUN) :573-577

[5]

FLEISCHMANN WR, 1980, J NATL CANCER I, V65, P963

[6] INTERFERON, PRE-CLINICAL BASIS FOR CLINICAL-TRIALS WITH FIBROBLAST INTERFERON IN JAPAN [J].

KATAOKA, T ;

SAKURAI, Y ;

IDA, N ;

KOBAYASHI, S .

CANCER TREATMENT REVIEWS, 1980, 7 (04) :253-256

[7]

LUDWIG H, 1980, CANCER IMMUNOL IMMUN, V9, P139

[8] QUANTITATION OF DIFFERENTIAL SENSITIVITY OF HUMAN-TUMOR STEM-CELLS TO ANTI-CANCER DRUGS [J].

SALMON, SE ;

HAMBURGER, AW ;

SOEHNLEN, B ;

DURIE, BGM ;

ALBERTS, DS ;

MOON, TE .

NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (24) :1321-1327

← 1 →